High EZH2 Expression in Ductal Carcinoma in Situ on Breast Core Needle Biopsy is an Independent Predictive Factor for Upgrade on Surgical Excision

Facility

Lenox Hill Hospital

Department

Department of Pathology

Status

Resident

Category

Clinical Science Research

Start Date

3-6-2020 12:00 AM

This document is currently not available here.

Share

COinS
 
Jun 3rd, 12:00 AM

High EZH2 Expression in Ductal Carcinoma in Situ on Breast Core Needle Biopsy is an Independent Predictive Factor for Upgrade on Surgical Excision